Literature DB >> 18436390

A score predicting posttreatment ambulatory status in patients irradiated for metastatic spinal cord compression.

Dirk Rades1, Volker Rudat, Theo Veninga, Lukas J A Stalpers, Hiba Basic, Johann H Karstens, Peter J Hoskin, Steven E Schild.   

Abstract

PURPOSE: To create a scoring system to predict ambulatory status after radiotherapy (RT) for metastatic spinal cord compression (MSCC). METHODS AND MATERIALS: On the basis of a multivariate analysis of 2096 MSCC patients, a scoring system was developed. This included the five prognostic factors significantly associated with post-RT ambulatory status: primary tumor type, interval between tumor diagnosis and MSCC, visceral metastases, motor function before RT, and time developing motor deficits before RT. The score for each factor was determined by dividing the post-RT ambulatory rate (as a percentage) by 10. Total scores represented the sum of the scores for each factor and ranged between 21 and 44 points. Patients were divided into five groups according to this score.
RESULTS: The post-RT ambulatory rates were 6% (24 of 389) for patients with scores of </=28 points, 44% (121 of 278) for those with 29-31 points, 70% (212 of 303) for those with 32-34 points, 86% (315 of 266) for those with 35-37 points, and 99% (750 of 760) for those with >/=38 points. The 3-month survival rates were 29%, 62%, 77%, 84%, and 98%, respectively. The 6-months survival rates were 6%, 31%, 42%, 61%, and 93%, respectively.
CONCLUSIONS: Because patients with scores of </=28 points had poor functional outcome after RT and extraordinarily poor survival rates, short-course RT to decrease pain or best supportive care may be considered. Patients with scores of 29-37 points should be considered surgical candidates, because RT-alone results were not optimal. Patients with scores of >/=38 points seem to have excellent results with RT alone.

Entities:  

Mesh:

Year:  2008        PMID: 18436390     DOI: 10.1016/j.ijrobp.2008.02.018

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  17 in total

Review 1.  Rehabilitation and treatment of spinal cord tumors.

Authors:  Vishwa S Raj; Latanya Lofton
Journal:  J Spinal Cord Med       Date:  2013-01       Impact factor: 1.985

2.  Postoperative survival and ambulatory outcome in metastatic spinal tumors : prognostic factor analysis.

Authors:  Kyung Yun Moon; Chun Kee Chung; Tae-Ahn Jahng; Hyun Jib Kim; Chi Heon Kim
Journal:  J Korean Neurosurg Soc       Date:  2011-09-30

3.  Spinal cord compression.

Authors:  Eduardo Santamaria Carvalhal Ribas; David Schiff
Journal:  Curr Treat Options Neurol       Date:  2012-08       Impact factor: 3.598

4.  Radiotherapy of Bone Metastasis in Breast Cancer Patients - Current Approaches.

Authors:  Petra C Feyer; Maria Steingraeber
Journal:  Breast Care (Basel)       Date:  2012-04-25       Impact factor: 2.860

Review 5.  Scoring system for prediction of metastatic spine tumor prognosis.

Authors:  Yasuaki Tokuhashi; Hiroshi Uei; Masashi Oshima; Yasumitsu Ajiro
Journal:  World J Orthop       Date:  2014-07-18

6.  A systematic and evidence-based approach to the management of vertebral metastasis.

Authors:  Richard L S Jennelle; Vani Vijayakumar; Srinivasan Vijayakumar
Journal:  ISRN Surg       Date:  2011-08-02

Review 7.  Evaluating ambulatory function as an outcome following treatment for spinal metastases: a systematic review.

Authors:  Lananh Nguyen; Nicole Agaronnik; Marco L Ferrone; Jeffrey N Katz; Andrew J Schoenfeld
Journal:  Spine J       Date:  2021-05-13       Impact factor: 4.297

8.  A new instrument for estimating the survival of patients with metastatic epidural spinal cord compression from esophageal cancer.

Authors:  Dirk Rades; Stefan Huttenlocher; Amira Bajrovic; Johann H Karstens; Tobias Bartscht
Journal:  Radiol Oncol       Date:  2015-03-03       Impact factor: 2.991

9.  A validated score estimating ambulatory status following radiotherapy of elderly patients for metastatic spinal cord compression.

Authors:  Dirk Rades; Jasmin N Evers; Volker Rudat; Amira Bajrovic; Johann H Karstens; Steven E Schild
Journal:  BMC Cancer       Date:  2014-08-14       Impact factor: 4.430

10.  Continuous controversy about radiation oncologists' choice of treatment regimens for bone metastases: should we blame doctors, cancer-related features, or design of previous clinical studies?

Authors:  Carsten Nieder; Adam Pawinski; Astrid Dalhaug
Journal:  Radiat Oncol       Date:  2013-04-10       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.